510(k) Report

510(k) · Cleared

Cleared

Uroject12 Syringe Lever

K190987510(k) SpecialCleared Dec 2, 2019231-day reviewClass II21 CFR 880.5860

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Urogen Pharma, Ltd. · QBL Piston Syringe Lever

Cleared on Dec 2, 2019 as substantially equivalent to K180345 (Urogen Pharma, Ltd., 2018) after a 231-day review. Its family tree reaches back 3 generations to 1982. 1 later device descends from it.

Decided
Dec 2, 2019
Review
231 days
Class
Class II
Product code
QBL
Recalls
None
Predicates
1

Its longest line of descent runs back 3 generations to K820164 (1982). 1 later device descends from it, 1 citing it directly.

  1. Root · 3 generations backK820164 Empty Sterile CarpujectSterling Drug, Inc. · 1982
  2. 2 generations backK063180 Isecure Syringe Cartridge HolderHospira, Inc. · 2006
  3. 1 generation backK180345 Uroject12 Syringe LeverUrogen Pharma, Ltd. · 2018
  4. This deviceK190987 Uroject12 Syringe LeverUrogen Pharma, Ltd. · 2019
  5. Descendant · cites it directly · 0 of its ownK203321 Cystoject Syringe LeverUrogen Pharma, Ltd. · 2020

Most influential descendants

Showing 1 of 1 · See all
  • K203321Cystoject Syringe LeverUrogen Pharma, Ltd. · 2020 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−3K820164Empty Sterile CarpujectSterling Drug, Inc.1982—
−2K063180Isecure Syringe Cartridge HolderHospira, Inc.2006—
−1K180345Uroject12 Syringe LeverUrogen Pharma, Ltd.2018—
0 (this device)K190987Uroject12 Syringe LeverUrogen Pharma, Ltd.2019—
+1K203321Cystoject Syringe LeverUrogen Pharma, Ltd.2020—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
202010
FIG. 1 — Lineage of K190987, 1982–2020Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in QBL? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new QBL device

  1. #1 K203321 Cystoject Syringe Leverscore 1.4 · 4 generations · no Class I recall
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K180345Uroject12 Syringe Lever
Summary page 4
…0.5860 Device Class 2 III. PREDICATE DEVICE Predicate device Uroject12 Syringe Lever, by UroGen Pharma, Ltd., Product code QBL, cleared under K180345. K190987…
Urogen Pharma, Ltd.2018—

What descends from it? (1)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K203321Cystoject Syringe LeverUrogen Pharma, Ltd.20200

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 37 years and passes through 3 companies; a new generation was cleared every 11.8 years on median.
  • None of the 3 ancestors has a recall.
  • Of its descendants, K203321 (Urogen Pharma, Ltd., 2020) has gone furthest, with 0 descendants of its own.

How does its category compare?

All QBL devices

QBL Piston Syringe Lever: FDA decisions, review times, recalls and adverse event reports over 20 years. 2019, this device’s year, is highlighted.

FDA decisions per year · QBL

1in 2020

2018: 12019: 12020: 1
2007high 1 (2018) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · QBL

Too few QBL 510(k)s in any year since 2007 to give a median.

Recalls per year · QBL

No recall names QBL since 2007.

Adverse event reports per year · QBL

2in 2023

2023: 2
2007high 2 (2023) · low 0 (2007)2025

MAUDE reports naming product code QBL, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20110—00
20120—00
20130—00
20140—00
20150—00
20160—00
20170—00
20181—00
20191—00
20201—00
20210—00
20220—00
20230—02
20240—00
20250—00
20260—0—

What is it indicated for?

The Uroject12 Syringe Lever Device is intended for use in the administration of sterile materials under aseptic conditions, in a clinical urology setting, by a clinician and in accordance with the best judgment of a physician.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K190987: Uroject12 Syringe Lever.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K190987

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026